Home
Vivos Therapeutics VVOS paid Bell & Lindsay $20K for lobbying in Q4 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $20,000
- Quarter
- Q4 2023
- Client
- Vivos Therapeutics
- Reported
- 24/01/19
Up 0.0% from last quarter
What else happened in Vivos Therapeutics around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Vivos Therapeutics's other lobbying reports
- Vivos Therapeutics
LobbyingVivos Therapeutics
LobbyingVivos Therapeutics
VVOS
$40K
$40K
Reported 07/20
for Q2
- Vivos Therapeutics
LobbyingVivos Therapeutics
LobbyingVivos Therapeutics
VVOS
$40K
$40K
Reported 04/20
for Q1
- Vivos Therapeutics
LobbyingVivos Therapeutics
LobbyingVivos Therapeutics
VVOS
$40K
$40K
Reported 01/20
for Q4 2025
- Vivos Therapeutics
LobbyingVivos Therapeutics
LobbyingVivos Therapeutics
VVOS
$10K
$10K
Reported 25/10/20
for Q3 2025
- Vivos Therapeutics
LobbyingVivos Therapeutics
LobbyingVivos Therapeutics
VVOS
$40K
$40K
Reported 25/07/21
for Q2 2025